Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease

CONCLUSION: Indirect comparison should be performed via Bayesian approach instead of frequentist inference with a fixed-effect model. Claiming the superiority of a specific medication over other therapies should be confirmed by findings originating from well-designed RCTs.PMID:38318884 | DOI:10.1080/17476348.2024.2316167
Source: Expert Review of Respiratory Medicine - Category: Respiratory Medicine Authors: Source Type: research